Cellphire Therapeutics is developing next generation allogeneic cellular therapeutics that harness the inherent biological capabilities of human cells. Our therapeutic platform consists of three technological capabilities:
Our lead product, Thrombosomes®, currently in Phase 2 clinical trials, is the starting point on the way to achieving our Vision. The technologies developed while creating Thrombosomes® enable a host of novel cellular therapies previously not possible.About our science
Discover yourself at Cellphire
We are looking for talented, innovative people to join us as we work to save lives by creating transformative, stabilized cellular therapeutics. Learn more about the work we do, our team, and the benefits we have to offer.
Cellphire is actively recruiting study sites for two Phase 2 clinical trials.
We are continually exploring new applications for stabilized cellular therapies.